Q3 Net Income Doubles to $14.5M as Longevity Fund Inflows Hit $452M; Outlook Raised Again
ABX sits 77% above its 52-week low of $5.04.
Summary
Abacus posted Q3 revenue of $76.9M, up 22% year over year, and GAAP net income of $14.5M versus $7.1M a year ago — a 105% jump driven by revenue growth and lower non-operating expense. Adjusted EPS (gross) came in at $0.29, up 20%, while adjusted EBITDA rose 12% to $42.3M and the margin slipped to 55.0% from 60.2%. The cash story is the standout: operating cash flow was $167.4M for the first nine months versus negative $18.2M a year earlier, and longevity fund inflows of $452.4M in the quarter were more than six times the prior-year period. Management raised its FY26 adjusted EPS outlook to $1.05-$1.07, the second raise this year, implying 22%-24% growth, and expects to fund its annual dividend through cash on hand and free cash flow. This follows the August 10-Q that showed H1 net income down 37% on a 76% expense surge — the Q3 print reverses that trend, and the September $400M investment-grade, oversubscribed securitization backs it up. The 5:00 p.m. ET call today is the next checkpoint on how much of the inflow pace carries into Q4.
At the time of this announcement, ABX was trading at $8.92 on NYSE in the Finance sector, with a market capitalization of approximately $855.7M. The 52-week trading range was $5.04 to $12.44. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.